Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: N05CM18

Dexdor(Dexmedetomidine hydrochloride)

Conscious Sedation

Marketing Authorisation Holder: Orion Corporation

EMA Authorisation: 15/09/2011

INN: dexmedetomidine

Indication

For sedation of adult intensive care unit patients requiring a sedation level not deeper than arousal in response to verbal stimulation (corresponding to Richmond Agitation-Sedation Scale (RASS) 0 to -3).

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Dexdor — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.